Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep, Metabolic, and Cardiovascular Dysfunction in PCOS
NCT00203996Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Sep 2003
- Primary completion
- Jun 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing Placebo, Pioglitazone and Leuprolide + E/P (3 arms). Primary endpoints: Apnea-Hypopnea Index at 8 weeks, Insulin Sensitivity Index (SI) and 1 more. Started Sep 2003; status: terminated.
02
Drugs
pioglitazoneleuprolide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT00203996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203996.